Teva reaches $75 million agreement with West Virginia to settle opioid-related claims
Reading time 1 min Christian Fernsby ▼ | May 26, 2022Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries and its affiliates, has reached an agreement with the Attorney General of West Virginia that settles the state’s and its subdivisions opioid-related claims.
The U.S. Teva Pharmaceuticals
Teva will also provide its life-saving medicine, the generic version of Narcan (naloxone hydrochloride nasal spray), valued at $27 million (wholesale acquisition cost), over 10 years.
The settlement structure is consistent with previously announced settlements. ■
"And learn that when you do make a mistake, you'll surface that mistake so you can get it corrected, rather than trying to hide it and bury it, and it becomes a much bigger mistake, and maybe a fatal mistake."
